Recent studies have demonstrated that long COVID‐19 is characterized by sustained endothelial dysfunction, including microvascular damage and impaired barrier integrity [83], processes that SIRT1 could be uniquely positioned to address, given its well‐documented protective effects on vascular tissue. The gene discussed is SIRT1; the disease is COVID-19.